CME Group vs Intercontinental Exchange CME vs ICE
CME Group and Intercontinental Exchange on one sheet: valuation multiples, growth, margins, debt, dividends and returns, each section labelled with the period it covers, from the companies' filings. Add or remove a stock above the sheet; the link holds the set.
CMEICE
What differs most
- Debt / equity: Intercontinental Exchange 0.7×, CME Group 0.1×.
- Price / sales: CME Group 15.6×, Intercontinental Exchange 6.8×.
- Net margin: CME Group 63.3%, Intercontinental Exchange 30.1%.
- Consensus revenue growth for next year: CME Group +8.1%, Intercontinental Exchange −12.2%.
Price return
2025-10-16 → 2026-10-16
CME+11.9%
ICE+5.3%
Profile
latestSector
Financial Services
Financial Services
Industry
Financial - Data & Stock Exchanges
Financial - Data & Stock Exchanges
Market value
$105.67B
$90.70B
Enterprise value
$106.95B
$110.70B
Employees
3,875
12,725
Revenue per employee (TTM)
$1.7M
$1.1M
Our models
nightlythe valuation on each stock's pagePrice vs model
18% overvalued vs model
39% overvalued vs model
Model range
$158–678
$65.22–312
Models in the headline
1
1
FCF growth priced in, at a 10% return
13.5%
14.1%
Every model, its assumptions and its range: CME valuation · ICE valuation. The growth priced in, at any return: CME reverse DCF · ICE reverse DCF.
Trading
close 2026-10-16Last close
$293.87
$161.56
52-week high
$326.46
$175.10
52-week low
$218.58
$122.91
Price vs 52-week high
−10.0%
−7.7%
Price vs 52-week low
+34.4%
+31.4%
Average daily volume / shares
0.8%
0.7%
Beta
0.27
0.94
Returns
to 2026-10-161 month
+7.9%
+4.8%
3 months
+19.3%
+14.0%
6 months
−0.8%
−1.3%
Year to date
+7.6%
−0.2%
1 year
+11.9%
+5.3%
1 year, dividends added
+16.3%
+6.7%
2 years
+29.4%
−2.2%
Valuation
price × TTM to Jun 2026P/E (TTM)
24.9×
22.8×
P/E on consensus EPS (next FY)
23.9×
19.8×
Price / sales
15.6×
6.8×
EV / sales
15.8×
8.2×
EV / EBITDA
—
15.8×
Price / book
4.0×
3.1×
Price / free cash flow (FY)
25.2×
21.1×
Free-cash-flow yield (FY)
4.0%
4.7%
Growth
TTM and FY2025Revenue growth (TTM)
—
—
Revenue growth, consensus next FY
+8.1%
−12.2%
Revenue, 3-year CAGR
9.1%
9.5%
Revenue, 5-year CAGR
6.0%
8.9%
EPS growth (TTM)
—
—
EPS growth, consensus next FY
+10.3%
+41.8%
EPS, 3-year CAGR
14.7%
30.8%
Free cash flow, 3-year CAGR
12.2%
8.8%
Diluted shares, 3-year change
+0.3%
+2.5%
Profitability
TTM to Jun 2026Gross margin (FY)†
86.1%
61.9%
Operating margin
65.1%
40.7%
EBITDA margin
—
52.3%
Net margin
63.3%
30.1%
Free-cash-flow margin (FY)
64.3%
33.9%
Return on equity
16.2%
13.7%
Return on assets
2.2%
2.3%
Asset turnover
0.03
0.08
† Gross margin (FY): As filed. Companies draw the cost-of-revenue line in different places, so gross margins of two companies in one industry can differ for that reason alone; operating margin does not depend on where the line is drawn.
Balance sheet
MRQ Jun 2026Cash
$2.14B
$1.07B
Total debt
$3.42B
$21.06B
Net debt
$1.28B
$20.00B
Debt / equity
0.1×
0.7×
Net debt / EBITDA (TTM)
—
2.9×
Interest coverage (FY)
32.6×
6.3×
Current ratio (FY)
92.97
1.02
Dividends
trailing 12 monthsDividend yield
3.8%
1.3%
Dividends per share
$11.30
$2.04
Payout ratio (of TTM EPS)
95.8%
28.8%
Dividend per share, 5-year CAGR
13.3%
9.6%
Frequency
Quarterly
Quarterly
Ownership and activity
last 90 days · latest 13FTracked superinvestors holding (13F)
8
7
Insider open-market buys (Form 4)
$79K
$0
Insider sales (Form 4)
$0
$6.5M
Analyst upgrades
0
0
Analyst downgrades
1
1
Statements
income TTM to Jun 2026 · cash flow FY2025Revenue
$6.77B
$13.43B
EBITDA
—
$7.02B
Operating income
$4.41B
$5.47B
Net income
$4.29B
$4.04B
EPS (diluted)
$11.79
$7.08
Operating cash flow
$4.28B
$4.66B
Capital expenditure
−$83.5M
−$373.0M
Free cash flow
$4.19B
$4.29B
Dividends paid
$3.93B
$1.10B
Keep comparing
Statements from the companies' SEC filings; prices, dividends and consensus estimates from Financial Modeling Prep; insider trades from Form 4 and holdings from 13F. Refreshed nightly. A comparison of filed numbers, not a recommendation to buy, sell or hold any security.